Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Localized HCC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Johns Hopkins

2023 Updates in Gastrointestinal Cancers
Videos
Events

Playback speed

10 seconds

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Localized HCC

By Johns Hopkins FEATURING Mari Nakazawa

42 views

November 7, 2024

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Videos

New

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

Johns Hopkins

M. Nakazawa

42 views

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - …

2024 ASCO® Annual Meeting Insights Hub

C. Paller

170 views

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Johns Hopkins

M. Baretti

272 views

ASH 2023 Insights: "A Comparison of HMAs Combined With Ivosidenib or…

Insights from 2023 ASH Annual Meeting

A. Ambinder

50 views

Output From the National MDS Study: Utility of Targeted Gene Sequenc…

Johns Hopkins

A. DeZern

205 views

Targeting BRAF-Altered Glioma in Adults

Johns Hopkins

K. Schreck

454 views

Severe Aplastic Anemia: What's on the Horizon?

Johns Hopkins

A. DeZern

557 views

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Johns Hopkins

M. Yarchoan

670 views

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

MedNews Week

M. Pishvaian

629 views

KRASG12C Mutation in NSCLC: Current Data and Future Directions

Johns Hopkins

S. Rosner

448 views